Mindray Medical (MR) Tops Q3 EPS by 6c; Revs Light
More News related to MR
- Mindray Medical Awarded Key Software Enterprise Status for 2009 Calendar Year
- Susquehanna Maintains a 'Positive' Rating on Mindray Medical (MR); Raises PT
- Mindray Medical (MR) Issues Better-Than-Expected FY09 Sales, EPS Guidance
- Mindray Medical Announces Preliminary 2009 Operating Results
- Mindray Medical to Present at CITI Hong Kong and China Mini Conference 2010
More News related to Earnings
- Baidu (BIDU) Blows the Lid Off Q4, Shares Jump
- Aspen Insurance (AHL) Posts Q4 adj.-EPS of $1.44, Tops Views
- Acadia Realty Trust (AKR) Misses Q4 FFO by 1c; Guides Below for FY10
- RenaissanceRe (RNR) Tops Q4 Views
- Taubman Centers (TCO) Reports Q4 FFO of $0.56; Guides FY10
Mindray Medical International Limited (NYSE: MR) reports Q3 EPS of $0.33, 6 cents better than estimates. Revenues were $151.1 million vs. $154.98 million consensus.
[SM]
Related Categories
EarningsStocks Mentioned
+0.85Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
